276 related articles for article (PubMed ID: 33990540)
21. MicroRNA-4458 Regulates PD-L1 Expression to Enhance Anti-tumor Immunity in NSCLC via Targeting STAT3.
Liu W; Liu R; Yuan R; Wang X
Mol Biotechnol; 2021 Dec; 63(12):1268-1279. PubMed ID: 34386930
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA SNHG5 Induces the NF-κB Pathway by Regulating miR-181c-5p/CBX4 Axis to Promote the Progression of Non-Small Cell Lung Cancer.
Kang S; Ou C; Yan A; Zhu K; Xue R; Zhang Y; Lai J
Arch Bronconeumol; 2023 Jan; 59(1):10-18. PubMed ID: 35963709
[TBL] [Abstract][Full Text] [Related]
23. miR-675 promotes disease progression of non-small cell lung cancer via activating NF-κB signaling pathway.
Feng Y; Yang C; Hu D; Wang X; Liu X
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):7-10. PubMed ID: 28719338
[TBL] [Abstract][Full Text] [Related]
24. The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients.
Li X; Yu Z; Li Y; Liu S; Gao C; Hou X; Yao R; Cui L
Int J Oncol; 2015 Feb; 46(2):798-808. PubMed ID: 25531908
[TBL] [Abstract][Full Text] [Related]
25. miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling.
Huang X; Xiao S; Zhu X; Yu Y; Cao M; Zhang X; Li S; Zhu W; Wu F; Zheng X; Jin L; Xie C; Huang X; Zou P; Li X; Cui R
Cell Death Dis; 2020 Sep; 11(9):785. PubMed ID: 32963220
[TBL] [Abstract][Full Text] [Related]
26. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
[TBL] [Abstract][Full Text] [Related]
27. Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis.
Ling Q; Wu S; Liao X; Liu C; Chen Y
BMC Cancer; 2022 Jul; 22(1):765. PubMed ID: 35836137
[TBL] [Abstract][Full Text] [Related]
28. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
Liu S; Ge X; Su L; Zhang A; Mou X
Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
[TBL] [Abstract][Full Text] [Related]
30. ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.
Ao YQ; Gao J; Jin C; Wang S; Zhang LC; Deng J; Chen ZW; Wang HK; Jiang JH; Ding JY
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38148115
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
Pan H; Pan Z; Guo F; Meng F; Zu L; Fan Y; Li Y; Li M; Du X; Zhang X; Shao Y; Wei M; Li X; Zhou Q
BMC Cancer; 2021 Nov; 21(1):1218. PubMed ID: 34774019
[TBL] [Abstract][Full Text] [Related]
32. Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching.
Zhou K; Li W; Chen L; Chen S; Liu M; Yang Z; Mao Z; Yu W
Hum Mol Genet; 2024 May; ():. PubMed ID: 38723288
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis.
Hu Y; Zhao Z; Jin G; Guo J; Nan F; Hu X; Hu Y; Han Q
Bioengineered; 2022 Apr; 13(4):10749-10764. PubMed ID: 35475457
[TBL] [Abstract][Full Text] [Related]
34. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
36. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
Li S; Mei Z; Hu HB; Zhang X
J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
[TBL] [Abstract][Full Text] [Related]
37. CircLARP4 Suppresses Cell Proliferation, Invasion and Glycolysis and Promotes Apoptosis in Non-Small Cell Lung Cancer by Targeting miR-135b.
Lu H; Guo Q; Mao G; Zhu J; Li F
Onco Targets Ther; 2020; 13():3717-3728. PubMed ID: 32440141
[TBL] [Abstract][Full Text] [Related]
38. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.
Cai J; Fang L; Huang Y; Li R; Yuan J; Yang Y; Zhu X; Chen B; Wu J; Li M
Cancer Res; 2013 Sep; 73(17):5402-15. PubMed ID: 23856247
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
40. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1α axis.
Zhang J; Han L; Yu J; Li H; Li Q
Aging (Albany NY); 2021 Apr; 13(7):10431-10449. PubMed ID: 33819917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
